返回 Agenda
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Head of Regulatory Science and Execution
Alexion, United States
Speaker(s)
Program for Enhanced Review Transparency and Communication for NME NDAs and Original BLAs
Kim Quaintance-Lunn
Alexion, United States
Vice President, Head of Regulatory Science and Execution
Expedited Development Programs
Khyati Roberts, RPH
Retired, United States
Retired
Structured Benefit/Risk & Patient Focused Drug Development
Jayne Ware, MPH, MSC
Merck Sharp & Dohme LLC, United States
Senior Director, Global Regulatory Policy